Leszek Pawelczyk

Leszek Pawelczyk

Auto-generated profile, based on publicly available information

Leszek Pawelczyk

Division of Infertility and Reproductive Endocrinology, Department of Gynecology, Obstetrics and Gynecological Oncology, Poznan University of Medical Sciences, 33 Polna St., 60-535 Poznań, Poland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
PTPedro J Torres
Pedro J Torres
MSMartyna Siakowska
Martyna Siakowska
BBBeata Banaszewska
Beata Banaszewska
LPLeszek Pawelczyk
Leszek Pawelczyk
ADAntoni J Duleba
Antoni J Duleba
VTVarykina G Thackray
Varykina G Thackray
Context A majority of women with polycystic ovary syndrome (PCOS) have metabolic abnormalities that result in an increased risk of developing type 2 diabetes and heart disease. Correlative studies have shown an association between changes in the gut microbiome and metabolic disorders. Two recent studies reported a decrease in alpha diversity of the gut microbiome in women with PCOS compared with healthy women. Objective We investigated whether changes in the gut microbiome correlated with specific clinical parameters in women with PCOS compared to healthy women. We also investigated whether there were changes in the gut microbiome in women with polycystic ovarian morphology (PCOM) that lacked the other diagnostic criteria of PCOS. Participants Subjects were recruited at the Poznan University of Medical Sciences. Fecal microbial diversity profiles of healthy women (n=48), women with PCOM (n=42), and women diagnosed with PCOS using the Rotterdam criteria (n=73) were analyzed using 16S rRNA gene sequencing. Results Lower alpha diversity was observed in women with PCOS compared with healthy women. Women with PCOM had a change in alpha diversity that was intermediate between the other two groups. Regression analyses showed that hyperandrogenism, total testosterone and hirsutism were negatively correlated with alpha diversity. PERMANOVA of UniFrac distances showed that hyperandrogenism was also correlated with beta diversity. Random Forest identified bacteria that discriminated between healthy women and women with PCOS. Conclusions These results suggest that hyperandrogenism may play a critical role in altering the gut microbiome in women with PCOS.

1 June 2000 in Fertility and Sterility
Verified
Journal Article
Open access
BKBeata Kolodziejczyk
Beata Kolodziejczyk
ADAntoni J Duleba
Antoni J Duleba
RSRobert Z Spaczynski
Robert Z Spaczynski
LPLeszek Pawelczyk
Leszek Pawelczyk
To evaluate the effects of 12 weeks of metformin therapy on hormonal and clinical indices in polycystic ovary syndrome (PCOS). Prospective study. University hospital. Thirty-nine women with PCOS and fasting hyperinsulinemia. Twelve weeks of therapy with oral metformin (500 mg three times per day). Levels of insulin, T, DHEAS, insulin-like growth factor-I (IGF-I), gonadotropins, and sex hormone-binding globulin (SHBG); and clinical symptoms including acne, hirsutism, and length of the menstrual cycle were assessed before and after treatment with metformin. Metformin therapy resulted in a significant decrease in fasting insulin and total T and an increase in SHBG, leading to a decrease in the free T index. In addition, there was a significant decline in mean body mass index, waist-hip ratio, hirsutism, and acne, as well as an improvement in the menstrual cycle. No changes in LH and LH-FSH ratio were observed. Multiple regression analysis demonstrated that the greatest decline of T and free T index in response to metformin was observed among patients with the most pronounced hyperandrogenemia. Subjects with elevated DHEAS differed from those with normal DHEAS in their responses to metformin treatment. Women with high DHEAS exhibited less improvement of menstrual cycle regularity, no change in hirsutism, and an increase in levels of IGF-I after treatment. Metformin treatment of women with PCOS results in a decline of insulin as well as total and bioavailable T, leading to significant improvement of clinical manifestations of hyperandrogenism. Responses to metformin are related to the severity of hyperandrogenemia and to adrenal function.

1 November 2016 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
BBBeata Banaszewska
Beata Banaszewska
JWJoanna Wrotyńska-Barczyńska
Joanna Wrotyńska-Barczyńska
RSRobert Z. Spaczynski
Robert Z. Spaczynski
LPLeszek Pawelczyk
Leszek Pawelczyk
ADAntoni J. Duleba
Antoni J. Duleba
Article published by the Endocrine Society Article published by the Endocrine Society

5 January 2007 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
Evanthia Diamanti-KandarakisEvanthia Diamanti-Kandarakis
Evanthia Diamanti-Kandarakis
Christina PiperiChristina Piperi
Christina Piperi
EPEfstratios Patsouris
Efstratios Patsouris
PKPenelope Korkolopoulou
Penelope Korkolopoulou
DPDimitrios Panidis
Dimitrios Panidis
ADAntoni J. Duleba
Antoni J. Duleba

14 November 2006 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
BBBeata Banaszewska
Beata Banaszewska
LPLeszek Pawelczyk
Leszek Pawelczyk
RSRobert Z. Spaczynski
Robert Z. Spaczynski
JDJames Dziura
James Dziura
ADAntoni J. Duleba
Antoni J. Duleba
Polycystic ovary syndrome (PCOS) is associated with hyperandrogenism and cardiovascular risks including dyslipidemia and systemic inflammation. In vitro, statins decrease proliferation and steroidogenesis of ovarian theca-interstitial cells. The study objective was to compare effects of two treatments of PCOS: simvastatin plus oral contraceptive pill (OCP) vs. OCP alone. In a prospective, crossover trial, 48 women with PCOS were randomized to either simvastatin plus OCP for 12 wk followed by OCP alone for an additional 12 wk, or to OCP alone for 12 wk and, subsequently, simvastatin plus OCP for an additional 12 wk. Evaluations were performed at baseline, after 12 wk (crossover), and after 24 wk. Data were analyzed using a random effects model. The study was conducted in an academic medical center. Serum total testosterone was the primary outcome measure. Total testosterone decreased by 38% after Statin + OCP, whereas OCP alone led to a 26% decrease; the statin-attributable effect was significant (P < 0.004). Free testosterone declined by 58% after Statin + OCP, significantly more than the 35% decline after OCP alone (P = 0.006). Hirsutism decreased by 8.1% after Statin + OCP, a greater effect than the 4.7% decrease after OCP alone (P = 0.02). Statin decreased LH, but not FSH or prolactin. Statin + OCP decreased total and low-density lipoprotein cholesterol by 7.5% and 20%, respectively. OCP alone led to a 5% increase of total cholesterol without effect on low-density lipoprotein cholesterol. Statin prevented OCP induced increase of triglycerides. C-reactive protein decreased by 45% after Statin + OCP, a significantly different effect (P = 0.006) than a 6% increase after OCP alone. Soluble vascular cell adhesion molecule 1 decreased by 18% after Statin + OCP, a greater decline than the 10% decrease after OCP alone (P = 0.01). Simvastatin improved endocrine/clinical aspects of PCOS and had beneficial effects on lipid profile and markers of systemic inflammation.

5 June 2021 in Cells
Verified
Journal Article
Open access
PDF file
CDClaudia Dompe
Claudia Dompe
MKMagdalena Kulus
Magdalena Kulus
KSKatarzyna Stefańska
Katarzyna Stefańska
WKWiesława Kranc
Wiesława Kranc
BCBłażej Chermuła
Błażej Chermuła
Bartosz KempistyBartosz Kempisty
Bartosz Kempisty
The ovarian follicle is the basic functional unit of the ovary, comprising theca cells and granulosa cells (GCs). Two different types of GCs, mural GCs and cumulus cells (CCs), serve different functions during folliculogenesis. Mural GCs produce oestrogen during the follicular phase and progesterone after ovulation, while CCs surround the oocyte tightly and form the cumulus oophurus and corona radiata inner cell layer. CCs are also engaged in bi-directional metabolite exchange with the oocyte, as they form gap-junctions, which are crucial for both the oocyte’s proper maturation and GC proliferation. However, the function of both GCs and CCs is dependent on proper follicular angiogenesis. Aside from participating in complex molecular interplay with the oocyte, the ovarian follicular cells exhibit stem-like properties, characteristic of mesenchymal stem cells (MSCs). Both GCs and CCs remain under the influence of various miRNAs, and some of them may contribute to polycystic ovary syndrome (PCOS) or premature ovarian insufficiency (POI) occurrence. Considering increasing female fertility problems worldwide, it is of interest to develop new strategies enhancing assisted reproductive techniques. Therefore, it is important to carefully consider GCs as ovarian stem cells in terms of the cellular features and molecular pathways involved in their development and interactions as well as outline their possible application in translational medicine.